Researchers have quantified the role of obesity in common long-term conditions, showing for the first time the effect of ...

At an Institute for Value-Based Medicine® (IVBM) event cohosted by The American Journal of Managed Care®, experts discussed efforts to implement obesity management science into practice. Obesity ...

Obesity is associated with multiple non-communicable diseases (such as type 2 diabetes, various cardiovascular and musculoskeletal diseases, and some cancers) and detrimental psychosocial consequences ...

The World Health Organization (WHO) has released its first guideline on the use of GLP-1 therapies for treating obesity in adults. Obesity currently affects more than 1 billion people globally — a ...

Obesity is often seen as a failure of willpower, but is, in fact, a disease: one caused by everything from socioeconomic conditions and family history to metabolic factors. For the 42% of US adults ...

The problem of overweight and obesity is a focus of attention of several professional communities of physicians, who publish authoritative guidelines focused on this growing health issue. In the ...

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 ...

It’s a new era in weight management and the treatment of overweight and obesity with the rise of glucagon-like peptide 1 receptor agonist medicines. Some patients are showing a new readiness and ...

Please provide your email address to receive an email when new articles are posted on . Guidelines say patients with obesity and asthma should lose between 5% and 10% of their weight. Primary care ...